Categories: News

New Virtual Reality Technology to Treat PTSD Enters Clinical Trials

ORLANDO, Fla., April 27, 2021 /PRNewswire/ — It’s estimated by the American Psychiatric Association that one in 11 people will be diagnosed with posttraumatic stress disorder (PTSD) in their lifetime, but new virtual reality (VR) technology is providing hope for the recovery of those suffering.

UCF RESTORES®, a nonprofit trauma research center and treatment clinic at the University of Central Florida, has developed a state-of-the-art VR treatment tool that can be customized to each patient’s traumatic experience, immersing them in the sights, smells and sounds of the original trauma. The center is now launching a clinical trial to study the effectiveness of this new VR tool in treatment of adults with PTSD as a result of a traumatic event that occurred in adulthood.

Individuals 18 years of age or older in the U.S. who meet the diagnostic criteria for PTSD are eligible to participate in this study. The treatment program – including a pre-treatment evaluation, two weeks of treatment, and post-treatment assessments – is available at no cost and hotel accommodations will be provided during the two-week treatment, as needed.  

Since 2011, UCF RESTORES has worked to change the way PTSD is understood, diagnosed and treated. The organization’s unique approach to treatment – combining exposure therapy, emerging technology, one-on-one and group therapy sessions – has resulted in 66% of participants with combat-related trauma and 76% of first responders no longer meeting the diagnostic criteria for PTSD following three weeks of intensive treatment.

The U.S. Department of Defense recognized the high success rate of RESTORES’ treatment and in 2018 awarded the clinic $3 million to develop this enhanced VR tool to address a wider range of traumatic events that could result in PTSD.

Until now, the organization’s use of VR in treatment has relied upon a third-party system with limited customization of its visual elements. This new VR tool will be used to test the efficacy of UCF RESTORES’ exposure therapy treatment in a further condensed, two-week intensive format.

“With this tool in hand, we will be able to dynamically recreate scenarios that are customized to each patient’s unique experience, ultimately helping them process traumatic memories, put them in their place and regain control of their daily lives,” said UCF RESTORES Executive Director Deborah Beidel, Ph.D., ABPP.

Those interested in participating in the study are encouraged to call UCF RESTORES at (407) 823-3910 for a confidential interview.

Media contact
Elizabeth Lytle
elytle@thestrategicfirm.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-virtual-reality-technology-to-treat-ptsd-enters-clinical-trials-301278448.html

SOURCE University of Central Florida

Staff

Recent Posts

Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution

- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…

1 day ago

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…

2 days ago

Defence Announces Closing of Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…

2 days ago

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

2 days ago